MicroRNA in central nervous system trauma and degenerative disorders

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) are a novel class of small noncoding RNAs that negatively regulate gene expression at the posttranscriptional level by binding to the 3=-untranslated region of target mRNAs leading to their translational inhibition or sometimes degradation. MiRNAs are predicted to control the activity of at least 20-30% of human protein-coding genes. Recent studies have demonstrated that miRNAs are highly expressed in the central nervous system (CNS) including the brain and spinal cord. Although we are currently in the initial stages of understanding how this novel class of gene regulators is involved in neurological biological functions, a growing body of exciting evidence suggests that miRNAs are important regulators of diverse biological processes such as cell differentiation, growth, proliferation, and apopto-sis. Moreover, miRNAs are key modulators of both CNS development and plasticity. Some miRNAs have been implicated in several neurological disorders such as traumatic CNS injuries and neurodegenerative diseases. Recently, several studies suggested the possibility of miRNA involvement in neurodegeneration. Identifying the roles of miRNAs and their target genes and signaling pathways in neurological disorders will be critical for future research. miRNAs may represent a new layer of regulators for neurobiology and a novel class of therapeutic targets for neurological diseases.

Original languageEnglish
Pages (from-to)571-580
Number of pages10
JournalPhysiological Genomics
Volume43
Issue number10
DOIs
StatePublished - May 2011

Fingerprint

Nervous System Trauma
MicroRNAs
Central Nervous System
Nervous System Diseases
Biological Phenomena
Small Untranslated RNA
Neurobiology
Central Nervous System Diseases
3' Untranslated Regions
Regulator Genes
Neurodegenerative Diseases
Cell Differentiation
Spinal Cord
Gene Expression
Messenger RNA
Brain

Keywords

  • Gene expression
  • Neurodegeneration
  • Neurological disorders
  • Traumatic CNS injury

ASJC Scopus subject areas

  • Physiology
  • Genetics

Cite this

MicroRNA in central nervous system trauma and degenerative disorders. / Liu, Naikui; Xu, Xiao-Ming.

In: Physiological Genomics, Vol. 43, No. 10, 05.2011, p. 571-580.

Research output: Contribution to journalArticle

@article{e8ba5cf553da4e21834994b2bac7f753,
title = "MicroRNA in central nervous system trauma and degenerative disorders",
abstract = "MicroRNAs (miRNAs) are a novel class of small noncoding RNAs that negatively regulate gene expression at the posttranscriptional level by binding to the 3=-untranslated region of target mRNAs leading to their translational inhibition or sometimes degradation. MiRNAs are predicted to control the activity of at least 20-30{\%} of human protein-coding genes. Recent studies have demonstrated that miRNAs are highly expressed in the central nervous system (CNS) including the brain and spinal cord. Although we are currently in the initial stages of understanding how this novel class of gene regulators is involved in neurological biological functions, a growing body of exciting evidence suggests that miRNAs are important regulators of diverse biological processes such as cell differentiation, growth, proliferation, and apopto-sis. Moreover, miRNAs are key modulators of both CNS development and plasticity. Some miRNAs have been implicated in several neurological disorders such as traumatic CNS injuries and neurodegenerative diseases. Recently, several studies suggested the possibility of miRNA involvement in neurodegeneration. Identifying the roles of miRNAs and their target genes and signaling pathways in neurological disorders will be critical for future research. miRNAs may represent a new layer of regulators for neurobiology and a novel class of therapeutic targets for neurological diseases.",
keywords = "Gene expression, Neurodegeneration, Neurological disorders, Traumatic CNS injury",
author = "Naikui Liu and Xiao-Ming Xu",
year = "2011",
month = "5",
doi = "10.1152/physiolgenomics.00168.2010",
language = "English",
volume = "43",
pages = "571--580",
journal = "Physiological Genomics",
issn = "1094-8341",
publisher = "American Physiological Society",
number = "10",

}

TY - JOUR

T1 - MicroRNA in central nervous system trauma and degenerative disorders

AU - Liu, Naikui

AU - Xu, Xiao-Ming

PY - 2011/5

Y1 - 2011/5

N2 - MicroRNAs (miRNAs) are a novel class of small noncoding RNAs that negatively regulate gene expression at the posttranscriptional level by binding to the 3=-untranslated region of target mRNAs leading to their translational inhibition or sometimes degradation. MiRNAs are predicted to control the activity of at least 20-30% of human protein-coding genes. Recent studies have demonstrated that miRNAs are highly expressed in the central nervous system (CNS) including the brain and spinal cord. Although we are currently in the initial stages of understanding how this novel class of gene regulators is involved in neurological biological functions, a growing body of exciting evidence suggests that miRNAs are important regulators of diverse biological processes such as cell differentiation, growth, proliferation, and apopto-sis. Moreover, miRNAs are key modulators of both CNS development and plasticity. Some miRNAs have been implicated in several neurological disorders such as traumatic CNS injuries and neurodegenerative diseases. Recently, several studies suggested the possibility of miRNA involvement in neurodegeneration. Identifying the roles of miRNAs and their target genes and signaling pathways in neurological disorders will be critical for future research. miRNAs may represent a new layer of regulators for neurobiology and a novel class of therapeutic targets for neurological diseases.

AB - MicroRNAs (miRNAs) are a novel class of small noncoding RNAs that negatively regulate gene expression at the posttranscriptional level by binding to the 3=-untranslated region of target mRNAs leading to their translational inhibition or sometimes degradation. MiRNAs are predicted to control the activity of at least 20-30% of human protein-coding genes. Recent studies have demonstrated that miRNAs are highly expressed in the central nervous system (CNS) including the brain and spinal cord. Although we are currently in the initial stages of understanding how this novel class of gene regulators is involved in neurological biological functions, a growing body of exciting evidence suggests that miRNAs are important regulators of diverse biological processes such as cell differentiation, growth, proliferation, and apopto-sis. Moreover, miRNAs are key modulators of both CNS development and plasticity. Some miRNAs have been implicated in several neurological disorders such as traumatic CNS injuries and neurodegenerative diseases. Recently, several studies suggested the possibility of miRNA involvement in neurodegeneration. Identifying the roles of miRNAs and their target genes and signaling pathways in neurological disorders will be critical for future research. miRNAs may represent a new layer of regulators for neurobiology and a novel class of therapeutic targets for neurological diseases.

KW - Gene expression

KW - Neurodegeneration

KW - Neurological disorders

KW - Traumatic CNS injury

UR - http://www.scopus.com/inward/record.url?scp=79957640347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957640347&partnerID=8YFLogxK

U2 - 10.1152/physiolgenomics.00168.2010

DO - 10.1152/physiolgenomics.00168.2010

M3 - Article

VL - 43

SP - 571

EP - 580

JO - Physiological Genomics

JF - Physiological Genomics

SN - 1094-8341

IS - 10

ER -